Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Burning Rock Biotech (BNR) EPS (Weighted Average and Diluted): 2021-2024

Historic EPS (Weighted Average and Diluted) for Burning Rock Biotech (BNR) over the last 4 years, with Dec 2024 value amounting to -$3.83.

  • Burning Rock Biotech's EPS (Weighted Average and Diluted) rose 89.84% to -$0.14 in Q1 2025 from the same period last year, while for Mar 2025 it was $13.86, marking a year-over-year decrease of 51.61%. This contributed to the annual value of -$3.83 for FY2024, which is 49.54% up from last year.
  • As of FY2024, Burning Rock Biotech's EPS (Weighted Average and Diluted) stood at -$3.83, which was up 49.54% from -$7.59 recorded in FY2023.
  • In the past 5 years, Burning Rock Biotech's EPS (Weighted Average and Diluted) ranged from a high of -$3.83 in FY2024 and a low of -$10.87 during FY2022.
  • For the 3-year period, Burning Rock Biotech's EPS (Weighted Average and Diluted) averaged around -$7.43, with its median value being -$7.59 (2023).
  • In the last 5 years, Burning Rock Biotech's EPS (Weighted Average and Diluted) decreased by 17.76% in 2022 and then soared by 49.54% in 2024.
  • Over the past 4 years, Burning Rock Biotech's EPS (Weighted Average and Diluted) (Yearly) stood at -$9.23 in 2021, then fell by 17.76% to -$10.87 in 2022, then soared by 30.18% to -$7.59 in 2023, then spiked by 49.54% to -$3.83 in 2024.